Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: June 27, 2022

PROPRANOLOL HYDROCHLORIDE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Propranolol Hydrochloride, and what generic alternatives are available?

Propranolol Hydrochloride is a drug marketed by Actavis Elizabeth, Adare Pharms Inc, Amta, Inwood Labs, Mylan, Nortec Dev Assoc, Upsher Smith Labs, Zydus Pharms Usa Inc, Baxter Hlthcare Corp, Chartwell Injectable, Fosun Pharma, Fresenius Kabi Usa, Hikma Farmaceutica, Smith And Nephew, Solopak, Hikma, Pai Holdings Pharm, Ani Pharms, Chartwell Rx, Dava Pharms Inc, Duramed Pharms Barr, Impax Labs Inc, Innogenix, Interpharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Lederle, Northstar Hlthcare, Purepac Pharm, Roxane, Sandoz, Schering, Strides Pharma, Superpharm, Teva, Vintage Pharms, Warner Chilcott, Watson Labs, and Watson Labs Teva. and is included in one hundred and thirty-seven NDAs.

The generic ingredient in PROPRANOLOL HYDROCHLORIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.

Summary for PROPRANOLOL HYDROCHLORIDE

US Patents:	0
Applicants:	39
NDAs:	137
Finished Product Suppliers / Packagers:	38
Raw Ingredient (Bulk) Api Vendors:	138
Clinical Trials:	307
Patent Applications:	3,643
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in PROPRANOLOL HYDROCHLORIDE?	PROPRANOLOL HYDROCHLORIDE excipients list
DailyMed Link:	PROPRANOLOL HYDROCHLORIDE at DailyMed

Drug patent expirations by year for PROPRANOLOL HYDROCHLORIDE

Recent Clinical Trials for PROPRANOLOL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tianjin Medical University General Hospital	Phase 2
Roswell Park Cancer Institute	N/A
Iqvia Pty Ltd	Phase 1

See all PROPRANOLOL HYDROCHLORIDE clinical trials

Pharmacology for PROPRANOLOL HYDROCHLORIDE

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

Medical Subject Heading (MeSH) Categories for PROPRANOLOL HYDROCHLORIDE

Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Vasodilator Agents

Anatomical Therapeutic Chemical (ATC) Classes for PROPRANOLOL HYDROCHLORIDE

C07AA	Beta blocking agents, non-selective
C07A	BETA BLOCKING AGENTS
C07	BETA BLOCKING AGENTS
C	Cardiovascular system

US Patents and Regulatory Information for PROPRANOLOL HYDROCHLORIDE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Innogenix	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	070322-005	Sep 24, 1986	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Northstar Hlthcare	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	078213-004	Jan 10, 2008	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Hikma	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	SOLUTION;ORAL	070979-001	May 15, 1987		RX	No	Yes	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Zydus Pharms Usa Inc	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	090321-004	Mar 25, 2011	AB	RX	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Actavis Elizabeth	PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; propranolol hydrochloride	TABLET;ORAL	070852-001	May 15, 1986		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Watson Labs	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	070382-001	Mar 19, 1987		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
Ivax Sub Teva Pharms	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	TABLET;ORAL	072068-001	Jul 29, 1988		DISCN	No	No	See Plans and Pricing	See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Harvard Business School

Johnson and Johnson

Mallinckrodt

Colorcon

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.